Aterian (ATER)CEO sold ~$270K

~$270K

Approx. value · 706K sh @ $0.382

Traded

Sep 25, 2026

Filed

Sep 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 2, 2026Company filing · Form 8-K · Listing notice, Executive changeReceived a notice from its stock exchange, and changed a top executive or board member“On September 4, 2026, Mr. Feldman, pursuant to such agreement, was terminated as Chief Financial Officer and principal financial officer, and Mr. Feldman was entitled to receive his severance benefits.”
2. Sep 23, 2026Company filing · Form 8-K · Change of control, Executive changeControl of the company changed hands, and changed a top executive or board member (and 1 more item)“On September 23, 2026, the Company received the resignation of Avraham Ben-Tzvi as a member of the Board and from all committees of the Board, effective September 25, 2026.”
3. Sep 25, 2026 · this disclosureInsiderCEO sold ~$270K of ATER shares in the open market

What came next

1. Oct 2, 2026Company filing · Form 8-K · Auditor change, Executive changeChanged its auditor, and changed a top executive or board member“On September 30, 2026, Mr. Rodriguez’s employment terminated pursuant to the Transition Agreement.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aterian

For Aterian, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ATER page.

Other recent filings by David E. Lazar, Chief Executive Officer

• SEC Form 4 at Bio Green Med Solution (BGMS)Aug 4, 2025
• SEC Form 4 at Bio Green Med Solution (BGMS)Feb 28, 2025
• SEC Form 4 at Fiee (FIEE)Dec 31, 2024

The full history of David E. Lazar, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Aterian

• SEC Form 4Jun 13, 2025
• SEC Form 4Jun 13, 2025
• SEC Form 4Jun 13, 2025
• SEC Form 4Jun 13, 2025
• SEC Form 4Jun 13, 2025
• SEC Form 4Jun 13, 2025

Everything OQRO holds on this company is on its ATER page.